Abiopharma

AC Immune First Quarter 2026 Financial and Corporate Updates

Belden Reports First Quarter 2026 Results

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease

Insmed to Present at May 2026 Investor Conferences

Domo and Formula 1 Driver Alex Albon Kick Off 2026 Season Showcasing How AI and Data Drive Elite Performance

Diebold Nixdorf Reports First Quarter Financial Results; Strong Growth in Revenue, Adjusted EBITDA and Adjusted EPS, with Free Cash Flow More Than Tripling Year-over-Year

Entegris Announces Appointment of Sukhi Nagesh as Chief Financial Officer

Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026

Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility

RedHill Biopharma - RedHills RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohns Disease